Described herein are pharmaceutical packaging systems which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate prescription drugs, these types of programs which include a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very very low permeability to ox